Posted by Michael Wonder on 10 Dec 2024
EMA publishes agenda for 9-12 December 2024 CHMP meeting
9 December 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Garadacimab
- Tocilizumab
- Acoramidis hydrochloride
- Aflibercept
- Sipavibart
- Zapomeran
- Nemolizumab
- Denosumab
- Guanfacine hydrochloride
- Imetelstat
- Ustekinumab
- Filgrastim
